Table 2 Baseline characteristics of cases and controls
From: Costs associated with adverse events among acute patients
Cases | Controls (weighted) | p-value | |
|---|---|---|---|
Patients (n) | 91 | 91 (1184 non-weighted) | |
Female (n) | 52 | 52 | |
Age (mean) | 66.3 | 66.4 | 0.965 |
Cost: 12 months before primary admission, mean EUR [95% CI] | 5383 [2998–7768] | 4765 [3561–5969] | 0.658 |